Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Novacyt recovers £12.2m in VAT after settling DHSC dispute

(Sharecast News) - Molecular diagnostics company Novacyt announced the successful recovery of £12.2m in VAT from HM Revenue and Customs (HMRC) on Thursday. The firm said it had already received the full amount, boosting its financial position.

It said the VAT reclaim was related to invoices issued to the UK Department of Health and Social Care (DHSC), which would no longer be paid following a recent dispute settlement.

As previously reported in the company's annual general meeting statement on 18 July, Novacyt said it had sought to reclaim the VAT as part of its financial strategy following the resolution of the dispute.

After settling the dispute, which included a £5m payment to the DHSC in early July, Novacyt's net cash position had improved by over £7m.

At 1446 BST, shares in Novacyt were up 24.45% at 112.5p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Auction Technology Group lowers full-year guidance as CFO steps down
(Sharecast News) - Auction Technology Group said it expects full-year revenues to be slightly shy of earlier guidance as it announced the resignation of its chief financial officer.
GSK to pay $2.2bn to settle Zantac lawsuits
(Sharecast News) - GSK has agreed to pay $2.2bn to settle about 80,000 Zantac lawsuits in the US.
Tritax EuroBox accepts Brookfield £557m offer as Segro trumped
(Sharecast News) - Canadian investment form Brookfield has trumped Segro's effort to buy warehouse owner Tritax EuroBox with an agreed £557m offer.
Thursday preview: US CPI, ECB minutes in the spotlight
(Sharecast News) - All eyes on Thursday will be on the week's key data release, the US consumer price index for the month of September.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.